Role of VASP Phosphorylation Assay in Monitoring the Antiplatelet Therapy

Role of VASP Phosphorylation Assay in Monitoring the Antiplatelet Therapy

Dual antiplatelet treatment with clopidogrel and aspirin represents standard regimen in prevention of thromboembolic events in patients with ischemic heart disease undergoing percutaneous coronary intervention (PCI). One of the greatest pitfalls of clopidogrel treatment is large inter-individual var...

Full description

Bibliographic Details
Main Authors:	Fedor Marian, Simonova R., Fedorova J., Skornova I., Duraj L., Samos M., Stasko J., Kovar F., Mokan M., Kubisz P.
Format:	Article
Language:	English
Published:	Sciendo 2013-03-01
Series:	Acta Medica Martiniana
Subjects:	acute coronary syndrome clopidogrel flow cytometry platelet reactivity vasodilator stimulated phosphoprotein (vasp)
Online Access:	https://doi.org/10.2478/acm-2013-0008

Similar Items

Anti-vasodilator-stimulated phosphoprotein (VASP) antibodies are associated with neuropsychiatric disorders in systemic lupus erythematosus
by: Chenxi Zhu, et al.
Published: (2024-09-01)

Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study
by: Chaoyue Hu, et al.
Published: (2018-06-01)

Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromes
by: Gabriele Crimi, et al.
Published: (2018-04-01)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
by: Satoshi Niijima, et al.
Published: (2018-03-01)

Defective Platelet Activation and Bleeding Complications upon Cholestasis in Mice
by: Nina Sarah Gowert, et al.
Published: (2017-04-01)

The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
by: Opstad Trine B, et al.
Published: (2011-03-01)

Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation
by: Ronald H. L. Li, et al.
Published: (2020-05-01)

Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer
by: Ying Wang, et al.
Published: (2019-04-01)

Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor
by: Fanny Mingant, et al.
Published: (2018-04-01)

VASP-mediated actin dynamics activate and recruit a filopodia myosin
by: Ashley L Arthur, et al.
Published: (2021-05-01)

Loss of Ena/VASP interferes with lamellipodium architecture, motility and integrin-dependent adhesion
by: Julia Damiano-Guercio, et al.
Published: (2020-05-01)

Identification of High Platelet Reactivity Despite ADP P2Y12 Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve
by: Cyril Mariethoz, et al.
Published: (2023-04-01)

VASP, HCLS1, MSN, and EZR: Key molecular beacons in the pathophysiology of perihematomal edema Post-Intracerebral hemorrhage
by: Jingjing Chen, et al.
Published: (2024-10-01)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases
by: Matej Samoš, et al.
Published: (2021-01-01)

VASP boosts protrusive activity of macroendocytic cups and drives phagosome rocketing after internalization
by: Sarah Körber, et al.
Published: (2022-04-01)

The effects of high intensity interval training on platelet aggregation and phosphorylation of VASPser239 in men with coronary heart disease
by: Akbar Nouri-habashi, et al.
Published: (2019-01-01)

Cardiovascular Functions of Ena/VASP Proteins: Past, Present and Beyond
by: Peter M. Benz, et al.
Published: (2023-06-01)

ASSOCIATION BETWEEN SMOKING AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL
by: K. Yu. Lukianets, et al.
Published: (2020-10-01)

Native proline-rich motifs exploit sequence context to target actin-remodeling Ena/VASP protein ENAH
by: Theresa Hwang, et al.
Published: (2022-01-01)

On-treatment platelet reactivity in the era of new ADP receptor blockers: data from a real-world clinical practice
by: Skornova I, et al.
Published: (2018-08-01)

Ena/VASP Protein-Mediated Actin Polymerization Contributes to Naïve CD8+ T Cell Activation and Expansion by Promoting T Cell–APC Interactions In Vivo
by: Monique M. Waldman, et al.
Published: (2022-06-01)

Protein phosphorylation : analysis of protein phosphorylation, protein kinases inhibirors and protein phossphatases/
by: Hunter, Tony, et al.
Published: (1991)

CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis
by: Hongli Li, et al.
Published: (2021-11-01)

The possibility of selecting optimal antiplatelet therapy in patients with coronary heart disease in terms of CYP2C19 polymorphism
by: O L Bockeria, et al.
Published: (2016-05-01)

Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
by: Fida Charif, et al.
Published: (2019-11-01)

Thrombocytopenia: diagnosis with flow cytometry and antiplatelet antibodies
by: João Carlos de Campos Guerra, et al.
Published: (2011-06-01)

Thrombocytopenia: diagnosis with flow cytometry and antiplatelet antibodies
by: João Carlos de Campos Guerra, et al.
Published: (2011-06-01)

[Letter to the Editor] Protein phosphorylation status is preserved following dual RNA and protein extraction using the Qiagen RNeasy Mini Kit
by: Ousseynou Sarr, et al.
Published: (2016-11-01)

FEATURES OF PLATELET HEMOSTASIS IN PATIENTS WITH VARIOUS SENSITIVITY TO ANTIPLATELET THERAPY IN STABLE ANGINA PECTORIS AFTER PLANNED PERCUTANEOUS CORONARY INTERVENTION
by: Pronko T. P., et al.
Published: (2017-12-01)

Triiodothyronine Potentiates Vasorelaxation via PKG/VASP Signaling in Vascular Smooth Muscle Cells
by: Sherin Samuel, et al.
Published: (2017-04-01)

Role of genetic factors on the effect of additional loading doses and two maintenance doses used to overcome clopidogrel hyporesponsiveness
by: Gustavs Latkovskis, et al.
Published: (2014-01-01)

Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention
by: Adam Wiśniewski
Published: (2021-01-01)

Total saponin from Korean Red Ginseng inhibits binding of adhesive proteins to glycoprotein IIb/IIIa via phosphorylation of VASP (Ser157) and dephosphorylation of PI3K and Akt
by: Hyuk-Woo Kwon, et al.
Published: (2016-01-01)

Predicted miRNAs suppressed cell proliferation and migration via FAK/VASP axis; Systems biology approach
by: Asghar Mohammadi, et al.
Published: (2022-01-01)

Expression of the phagocytic receptors αMβ2 and αXβ2 is controlled by RIAM, VASP and Vinculin in neutrophil-differentiated HL-60 cells
by: Alvaro Torres-Gomez, et al.
Published: (2022-09-01)

Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway
by: Haiqun Chen, et al.
Published: (2018-07-01)

Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack
by: Kailash Krishnan, et al.
Published: (2023-05-01)

Dual versus single antiplatelet therapy in patients with nonminor ischemic stroke: a meta-analysis
by: Izabela Orlandi Môro, et al.
Published: (2025-02-01)

Antiplatelet therapies: An overview
by: Gundu H R Rao
Published: (2016-01-01)